Cogent Biosciences, Inc. (COGT)

39.97 +0.79 (+2.02%) USD  |  NASDAQ  |  Feb 25, 16:00
39.98 +0.01 (+0.03%) After-Hours: 20:00
More

Cogent Biosciences Stock Based Compensation (Annual)

Stock Based Compensation (Annual) Chart

View Stock Based Compensation (Annual) for COGT.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Stock Based Compensation (Annual) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Stock Based Compensation (Annual) Range, Past 5 Years

View Stock Based Compensation (Annual) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Stock Based Compensation (Annual) Benchmarks

View Stock Based Compensation (Annual) Benchmarks
Start Trial
Merck & Co., Inc. --
Sarepta Therapeutics, Inc. Upgrade
Cidara Therapeutics, Inc. Upgrade
BridgeBio Pharma, Inc. Upgrade
Olema Pharmaceuticals, Inc. Upgrade